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Concerns about climate change and the search for renewable energy sources together
with the goal of attaining sustainable product manufacturing have boosted the use of
microbial platforms to produce fuels and high‐value chemicals. In this regard, Yarrowia
lipolytica has been known as a promising yeast with potentials in diverse array of bio-
technological applications such as being a host for different oleochemicals, organic acid,
and recombinant protein production. Having a rapidly increasing number of molecular
and genetic tools available, Y. lipolytica has been well studied amongst oleaginous yeasts
and metabolic engineering has been used to explore its potentials. More recently, with
the advancement in systems biotechnology and the implementation of mathematical
modeling and high throughput omics data‐driven approaches, in‐depth understanding of
cellular mechanisms of cell factories have been made possible resulting in enhanced
rational strain design. In case of Y. lipolytica, these systems‐level studies and the related
cutting‐edge technologies have recently been initiated which is expected to result in
enabling the biotechnology sector to rationally engineer Y. lipolytica‐based cell factories
with favorable production metrics. In this regard, here, we highlight the current status of
systems metabolic engineering research and assess the potential of this yeast for future
cell factory design development.
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1 | INTRODUCTION
Limited fossil fuel resources as well as the growing environmental con-
cerns associated with their extraction necessitate a substitute for the
traditional chemical synthesis of valuable chemicals. As a renewable and
sustainable alternative, microbial biotechnology has been proven efficient
to produce high value chemicals (Timmis et al., 2017). Accordingly, an
array of microorganisms, from bacteria to yeasts, fungi, and microalgae
can be utilized as cell factories to produce a wide range of bioproducts.
Among these, Yarrowia lipolytica is increasingly gaining popularity as a
biotechnologically relevant cell factory to the extent that it is already
regarded to as the most promising nonconventional yeast in biopro-
duction industry (Markham & Alper, 2018). Most notably, Y. lipolytica is a
well‐known oleaginous yeast which can be used to produce lipids and
fatty acid‐derived bio‐based compounds (Blazeck et al., 2014).
Generally, the emerging interest in Y. lipolytica among both industry
and academia is further rooted in other advantages such as having GRAS
(generally recognized as safe) status (Groenewald et al., 2014), availability
of various tools for genetic manipulation (Madzak, 2018), tolerance to
different industrial conditions such as different pH values, higher salt
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concentration or the presence of organic acids, high capacity to channel
nutrients to commodity chemicals via the efficient flux through the tri-
carboxylic acid (TCA) cycle (Bilal et al., 2020), and also high potentials in
biosynthesis and secretion of proteins (Soudier et al., 2019). Besides
being a desirable host for bioproduction, Y. lipolytica has also been a
model organism for research on the biology and physiology of di-
morphism, hydrophobic substrate utilization, protein secretion, and more
importantly, lipid metabolism (Beckerich et al., 1998; Beopoulos
et al., 2009; Domínguez et al., 2000; Fickers et al., 2005).
Given the broad use of Y. lipolytica as an important micro-
organism with biological relevance and biotechnological applications,
significant efforts have been made to expand the knowledge of this
yeast. More recently, with the advancements in omics techniques, a
quantitative systems‐level insight into cellular organizations has
made possible to make valuable contributions to bioprocessing
(Campbell et al., 2017). Apparently, being able to analyze the entire
genome as well as globally quantifying all cellular components and
their interactions, does not only expand our knowledge of the biol-
ogy of the system under study, but also greatly improves the quality
of cell factory design. In general, there are multiple biotechnologi-
cally important metabolites produced by Y. lipolytica and the appli-
cation of systems metabolic engineering is in its infancy for this
yeast. Therefore, it is beneficial to provide an assessment of the
state‐of‐the‐art, to evaluate which approaches have let to promising
results and where future research should be directed to. Herein,
recent advances in the implementation of systems metabolic en-
gineering in optimizing Y. lipolytica as a cell factory is being reviewed.
2 | Y. LIPOLYTICA AS A CELL FACTORY
The industrial application of Y. lipolytica has over half a century of history
that began with the discovery of its high lipolytic and proteolytic activity.
These features enable the yeast to grow on a diverse range of lipid or
protein‐rich materials, where many of them can be considered as cheap
substrates. The high capacity of lipase secretion was leveraged on by
British Petroleum from 1950s through the 1970s, to pioneer the pro-
duction of single‐cell protein (SCP) from n‐alkanes as substrate
(Groenewald et al., 2014). SCP production based on Y. lipolytica is still
available as animal feed additive but on a smaller scale (Ritala
et al., 2017).
Starting from 2000s and following the development of molecular
and genetic tools for engineering the yeast, research studies, as well as
commercial productions, have been oriented towards leveraging the
abilities of the yeast to produce more than 100 different recombinant
proteins, polyalcohols, aromas, emulsifiers, and various organic acids
(primarily citric acid) from industrial waste or by‐products (Ledesma‐
Amaro & Nicaud, 2016; Markham & Alper, 2018; Miller & Alper, 2019).
In addition, the oleaginous phenotype of Y. lipolytica has been of interest
as it renders the yeast a promising oleaginous cell factory that can
produce oils and fatty acid‐derived compounds. Two products, New
Harvest™ EPA oil and Verlasso® salmon are commercial examples of this
feature and contain omega‐3 fatty acids for which there have been many
clinical studies showing a wide range of health benefits (Xie et al., 2015).
Generally, oils and fatty acid‐derived compounds from Y. lipolytica can be
used as, for example, biodiesel as well as ingredients for food and cos-
metic industries (Miller & Alper, 2019).
Since lipid biosynthesis is one of the most important features of Y.
lipolytica as a cell factory, a short overview of general lipid metabolism
will be given (also depicted in Figure 1) while the details can be found
elsewhere (Fakas, 2017; Lazar et al., 2018). Briefly, triacylglycerol (TAG)
lipid species function as storage carbohydrates and can be biosynthesized
either de novo or ex novo. The de novo lipid biosynthetic pathway is
enhanced by metabolic imbalance upon an essential nutrient limitation in
the growth media. In particular, under nitrogen starvation, the carbon
flux is redirected towards TAG biosynthesis, by a mechanism where the
TCA cycle enzyme isocitrate dehydrogenase is inhibited due to low levels
of the allosteric activator adenosine monophosphate (AMP) that is rather
broken down to yield ammonium. The ex novo pathway is based on the
ability of Y. lipolytica to grow on a wide range of hydrophobic carbon
sources (Beopoulos et al., 2009). Whether produced de novo or ex novo,
lipids can accumulate in a dynamic storage compartment called the lipid
body which mainly accommodates neutral lipids such as TAGs, while lipid
precursors such as malonyl‐CoA can likewise be diverted to alternative
products. Metabolism of lipid biosynthesis and accumulation is well
studied in Y. lipolytica, comprehensive understanding of which is vital for
opting any further systems metabolic engineering approach to improve
the production. It is important to note that while wild‐type Y. lipolytica
strains are typically inefficient in de novo lipid biosynthesis from sugars in
an industrial scale (Blazeck et al., 2014), various strains have been ge-
netically engineered to reach high lipid contents, where systems‐level
approaches are found promising in enhancement of production metrics
and approaching the maximum theoretical yield.
3 | WET ‐LAB TOOLS TO FACILITATE
SYSTEMS ANALYSIS
The availability of well‐established genome modification techniques
is an essential factor for optimizing microbial cell factories. In addi-
tion to wide availability of basic genetic engineering tools (i.e., host
strains and markers, vectors, promoters, terminators, and replication
elements) and conventional genetic modification methods, there is a
continuing effort in developing modern gene/genome editing sys-
tems for Y. lipolytica that can greatly speed up the application of this
yeast in systems biotechnology (comprehensively reviewed in
Ganesan et al., 2019). Briefly, from 2016, several efficient
CRISPR–Cas9 systems for single and multigene editing as well re-
pression or activation of genes in Y. lipolytica are being developed
(Gao et al., 2016; C. Schwartz et al., 2017, 2018; C. M. Schwartz
et al., 2016; Z. Yang et al., 2020). The gene integration efficiency of
up to 55% has been achieved using a homology‐independent tar-
geted genome integration tool mediated by CRISPR/Cas9 which does
not require the construction of homologous templates (Cui
et al., 2021). More recently, a dual‐purpose CRISPR‐Cpf1 system has
been suggested that is capable of simultaneous gene disruption and
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gene regulation in Y. lipolytica (Ramesh et al., 2020). Furthermore, a
suite of genetic tools (EasyCloneYALI) has been generated that fa-
cilitates transformation protocols by providing a series of pre‐
designed plasmids and oligos (Holkenbrink et al., 2018). There is still
a significant opportunity to further improve CRISPR‐based systems
in Y. lipolytica in terms of gene integration efficiency (similar to gene
disruption efficiency of about 90%), multigene editing efficiency or
the need for a high‐throughput screening technology after genome
editing. Although the application of the CRISPR‐Cas9 usage and its
innovative strategies in the model yeast, Saccharomyces cerevisiae,
shed light and laid the foundation of CRISPR‐Cas9 implementation in
other nonconventional yeasts technology, its optimizations need
species‐specific studies. However, there are several general factors
that have been proven in this reference yeast to positively affect the
efficiency of CRISPR‐Cas9 genome modifications amongst which
using weak to a medium‐strength promoter for expressing CAS9, a
priority of using natural RNAP III promoters, careful choice of the
gRNA binding site and taking advantage of in silico tools for sgRNAs
F IGURE 1 Overview of lipid metabolism in Yarrowia lipolytica solid arrows: chemical conversions and transport reactions, dashed arrows:
multiple chemical conversion steps, dotted lines and arrows: representing N‐limitation consequences. AMP, adenosine monophosphate; Cit,
citrate; DAG, diacylglycerol; DHAP, dihydroxyacetone phosphate; F6P, fructose 6‐phosphate; FA, fatty acid; FBP, fructose 1,6‐bisphosphate;
Fum, fumarate; G3P, glycerol 3‐phosphate; G6P, glucose 6‐phosphate; GA3P, glyceraldehyde 3‐phosphate; Icit, isocitrate; IMP, inosine
monophosphate; LPA, lysophosphatidic acid; Mal, malate; Mal‐CoA, malonyl coenzyme A; NH4, ammonium; OAA, oxaloacetate; PA,
phosphatidicacid; Pyr, pyruvate; Suc, succinate; TAG, triacyglycerol [Color figure can be viewed at wileyonlinelibrary.com]
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design to decrease off‐target effect can be named (Cai et al., 2019;
Raschmanová et al., 2018). When optimized, these systems provide a
suitable platform to be coupled with the systems‐level tools to fur-
ther promote the systems metabolic engineering process.
Meanwhile, and in parallel with studies to optimize CRISPR‐Cas9
systems for Y. lipolytica, other genome modification strategies are being
developed mainly due to the little information on CRISPR‐Cas9 related
molecular tools in this yeast. For instance, a Cre/lox‐site‐specific re-
combination system using only a single selection marker has been de-
veloped for targeted, repeated, and marker‐less gene integration in Y.
lipolytica with above 90% efficiency. Unlike similar previous methods
based on Cre/lox‐site‐specific recombination, their genetic tool was also
proved effective for various genes, loci, and strains which suggests a
promising application of Cre/lox system and strengthens its capabilities
for genome modification in Y. lipolytica (Zhou et al., 2021). Moreover, as a
study to overcome the challenge with building complex pathways and
multiple gene integration in Y. lipolytica, Z. Guo et al. (2020) have de-
signed a completely synthetic Y. lipolytica‐specific artificial chromosome
(ylAC) and successfully used it to introduce a complete cellobiose and
xylose co‐utilization pathway introduced to the yeast in a single step
within less than one week of wet lab experimentation. The method thus
is much faster and efficient in comparison to conventional multistep
procedures and can be applied for multigene integration in Y. lipolytica.
Based on existing efforts to create orthogonal systems where the syn-
thetic biology parts of one yeast have been applied to another (Patra
et al., 2021), it is expected that in near future, the synthetic biology tools
and techniques will be applied interchangeably among different species.
In all, recent advances have provided Y. lipolytica with a plethora
of genetic engineering and genome editing techniques (Holkenbrink
et al., 2018; Madzak, 2018), widening the perspectives for systems
metabolic engineering of Y. lipolytica as a potential biotechnological
workhorse.
4 | SYSTEMS METABOLIC ENGINEERING
OF Y. LIPOLYTICA
The functional genomics revolution and increasing ease of omics data
generation and computational analysis aids in understanding the
mechanisms of complex biological systems and the prediction of their
dynamic properties via systems biology. This paradigm of studying a
cell as a whole is being efficiently implemented to provide a holistic
view of the functioning of microbial cell factories with the goal of
rational re‐designing or creating new cellular functions in these
organisms.
Under the moniker of metabolic engineering, modifications of
biochemical pathways have been used for decades to achieve desired
phenotypes such as overproduction of a metabolite in cell factories,
either using random mutagenesis or other conventional molecular
genetic engineering tools. However, only after the development of
the methods and tools in the discipline of systems biology has it
become practical to approach the metabolic engineering challenges
from a systems perspective. The development of an optimal strain via
systems metabolic engineering can be performed through two major
approaches: omics data‐driven (top‐down) and biomolecular model‐
driven (bottom‐up). While the bottom‐up approach starts with the
reconstruction of an accurate mathematical model of a specific bio-
molecular subsystem (i.e., metabolic, gene regulatory and signaling
networks, or combinations thereof) using existing biological knowl-
edge; the top‐down approach begins with extracting information
from relevant omics data sets (e.g., metabolomics, proteomics, tran-
scriptomics, and fluxomics). Figure 2 illustrates these strategies as
well as the classic metabolic engineering.
During the past decade, there have been multiple studies on
biomolecular model analysis and omics data generation that aimed to
improve the understanding and production of many valuable meta-
bolites in Y. lipolytica. Genome‐scale metabolic models (GEMs) are
the most commonly studied biomolecular networks, the popularity of
which arises not only from their innate nature which directly con-
siders the analysis of the metabolite production phenotype, but also
from the availability of powerful constraint‐based modeling methods.
As GEMs can provide a global view of cellular metabolism, they are
influential tools in systems metabolic engineering. Currently, there
have been six GEMs published for Y. lipolytica by different research
groups, where each model includes improvements over previously
published models. All six GEMs have been used for evaluating me-
tabolic engineering strategies with a major focus on over‐producing
lipids, for example, triacylglycerols (TAGs) and to a lesser extent for
the increased dicarboxylic acids production (Kavšček et al., 2015;
Kerkhoven et al., 2016; Loira et al., 2012; Mishra et al., 2018; Pan &
Hua, 2012; Wei et al., 2017).
Since obtaining high‐quality omics data has become progres-
sively easier, interest in applying data‐driven approaches for ac-
quiring systems‐level knowledge of Y. lipolytica have increased
(Ledesma‐Amaro & Nicaud, 2016). While the availability of com-
plete genome sequences reveal its metabolic pathways and func-
tional potential, various transcriptomics and a few proteomics
analyses have provided useful information about the dynamics of
biological processes, such as the transition from the growth phase to
the lipid accumulation phase as well as its regulatory mechanisms
(Morin et al., 2011). There have also been a few metabolomics and
lipidomics analyses in Y. lipolytica, which further provide information
on the metabolic pathways under study by incorporating the changes
in metabolite concentrations (Zhao et al., 2015).
As individual omics analyses (e.g., transcriptomics or metabo-
lomics) are not always able to fully elucidate the behaviors of a
cellular system, combining different omics data (e.g., transcriptomics
and metabolomics) may result in a more precise picture of the bio-
logical system being studied. Moreover, integration of various types
of omics data following a bottom‐up approach can boost the pre-
dictive capability of the model (Gu et al., 2019). Such combinatory
approaches have been applied in a few studies in metabolic en-
gineering of Y. lipolytica.
Generally, examples of systems‐level understanding as well as
metabolic engineering efforts in Y. lipolytica powered by systems
biology knowledge and tools will be discussed below in relative
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sections. Furthermore, Table 1 summarizes the systems‐level opti-
mizations of lipid‐derived as well as nonlipid products in Y. lipolytica.
4.1 | Lipids and fatty acid‐derived products
Various studies have been performed to gain a systems‐level un-
derstanding of lipid metabolism with focus on three main questions:
the main source of NADPH that lipid accumulation demands; gene
regulation that coincides with lipid accumulation; and transcription
factor networks that are underlying the expressional changes during
lipid accumulation as will be detailed below. In many cases, such
studies have not only expanded our knowledge of various aspects of
lipid metabolism, but also yielded proposed targets for genetic en-
gineering for improved lipid production.
Lipid biosynthesis has a high NADPH demand that could theo-
retically be provided through various metabolic pathways. Based on
a comparison of flux distribution obtained by 13C metabolic flux
analysis in two strains of Y. lipolytica, one of which was engineered to
produce lipids at roughly twice the yield of the wild strain,
Wasylenko et al. (2015) concluded that the oxidative pentose
phosphate pathway (PPP) is the almost exclusive source of lipogenic
NADPH when Y. lipolytica is grown on glucose. However, when cul-
tured on acetate, another flux distribution analysis by N. Liu et al.
(2016) showed the importance of gluconeogenesis on lipogenic
NADPH synthesis.
To reveal if lipid accumulation is transcriptionally regulated, the
first transcriptomics analysis of Y. lipolytica during its metabolic shift
from growth to lipid accumulation indeed showed significant differ-
ence between the expression profile of actively dividing and lipid
accumulating cells (Morin et al., 2011). However, the genes directly
governing fatty acid synthesis were not transcriptionally regulated,
but rather, the authors hypothesized that lipid accumulation is a
passive consequence of the rerouting of carbon fluxes. Upon nitro-
gen deprivation a cascade of transcriptional events is triggered that
result in an increased supply of precursor and cofactors necessary
for the synthesis of lipids. Subsequent transcriptomics as well as
multiomics studies confirmed this hypothesis and elucidated the
regulatory role of protein and amino acid metabolism in lipogenesis
rather than the transcriptional regulation of lipid metabolism itself.
F IGURE 2 Schematic procedure of classic versus systems metabolic engineering and the major identified engineering targets for lipogenesis
in Yarrowia lipolytica by each strategy [Color figure can be viewed at wileyonlinelibrary.com]
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By integrating proteome, phosphoproteome and metabolome data,
Pomraning et al. (2016) suggested posttranslational modification of
key lipogenesis enzymes as the governing regulatory mechanism.
Specifically, ATP‐citrate lyase and acetyl‐CoA carboxylase (ACC)
were not differentially expressed but their level of phosphorylation
increased when cells were grown in media with low nitrogen avail-
ability, suggesting that this contributes to increased lipid accumula-
tion, which would be orthologous to the phosphorylation sites of S.
cerevisiae Acc1 that have been leveraged to enhance lipogenesis in
that species (Shi et al., 2014). In Y. lipolytica, later studies showed
that genes related to branched‐chain amino acid metabolism were
downregulated upon nitrogen limitation, while alternative nitrogen
supply pathways such as protein turnover and autophagy genes were
upregulated among which an important factor that affects lipid
synthesis was reported to be the metabolism of leucine (Kerkhoven
et al., 2016, 2017). These findings were similar the results from a
multiomics study of another oleaginous yeast, Rhodosporidium tor-
uloides (Zhu et al., 2012). Here, the transcriptomic and proteomic
data suggest that lipid accumulation under nitrogen‐limited condi-
tions correlates with the macromolecule metabolism and autophagy
which may denote to similarities in the mechanisms of microbial
oleaginicity. In an independent research where links between dis-
ruption of the MHY1 gene, involved in dimorphic transition in Y.
lipolytica, and lipid accumulation have been studied, transcriptome
data from the MHY1 mutant strain showed decreased amino acid
biosynthesis while lipid accumulation increased by 13% based on cell
dry weight (G. Wang et al., 2018).
To elucidate if regulatory networks are underlying lipid accumula-
tion, Trébulle et al. (2017) inferred a genome‐wide coregulatory network
using CoRegNet on the basis of the gene expression data during lipid
accumulation under nitrogen limitation. According to their reconstructed
regulatory network, network modules representing different transcrip-
tional programs, from growth to lipid accumulation phases, along with
the most influential new transcription factors (TFs) and co‐regulators
have been identified. Furthermore, the role of the top candidates on lipid
accumulation was validated experimentally using a high throughput
overexpression system (Leplat et al., 2018). Based on the identified
regulators and target genes, their findings again support the hypothesis
that lipid accumulation is a consequence of change in carbon fluxes ra-
ther than an enhanced lipid metabolism (Trébulle et al., 2017). Accord-
ingly, the tuning of key regulators can effectively facilitate lipid
accumulation by enhancing the carbon flux. Different regulators have
been identified in this regard. For instance, in separate studies deletion of
glucose repression regulators SNF1 and MIG1, have resulted in 2.6‐ and
1.5‐fold increase in lipid content of Y. lipolytica, respectively (Seip
et al., 2013; Z.‐P. Wang et al., 2013). Through reducing the flux to TCA
cycle by imbalancing the TCA cycle intermediates, deletion of UGA2 have
also resulted in 1.5‐fold enhanced lipid content (L. Liu et al., 2015). As
another example of tuning carbon flux via regulators is the mutation into
Mga2p, a regulator of desaturase gene expression, which resulted in
enhances lipid titer due to imbalance caused between glycolysis and the
TCA cycle (L. Liu et al., 2015). It is thus noteworthy that effective systems
biology approaches such as multiomics studies (e.g., integration of
transcriptome and metabolome data) integrated with in silico metabolic
model simulations could be used to analyze regulatory dynamics
(Hubbard et al., 2018), and from this transpired that lipid accumulation is
not merely an effect of isocitrate dehydrogenase inhibition during ni-
trogen starvation.
Beyond employing systems‐level approaches to gain under-
standing on lipid metabolism, it has been used to find systems‐level
solutions that favor the oleaginous phenotype in terms of improving
its yield, productivity, and titer as well as broadening the substrate
range. Nonetheless, most studies that have improved lipid produc-
tion can be classified as classical metabolic engineering, via over-
expression of genes that are directly involved in lipid biosynthesis,
deletion of those involved in lipid degradation, expressing genes
required for the consumption of different carbon sources, balancing
cofactors, as well as a combination of these strategies which are
comprehensively discussed elsewhere (Abdel‐Mawgoud et al., 2018;
Das et al., 2020; Lazar et al., 2018). While rationally designed clas-
sical metabolic engineering has been able to push lipid accumulation
to laudable levels, systems‐level approaches would be able to also
reach the uncharted territories of the lipogenesis metabolic land-
scape that would harbor a strain that is robust, versatile, and pushes
lipid accumulation to its limits. Systems metabolic engineering efforts
in Y. lipolytica have therefore aimed to approach the theoretical
maximal yield via understanding the less intuitive limiting factors and
based on conclusions formulated in omics and model‐based studies.
Accordingly, using a bottom‐up approach through the analysis of
a manually reconstructed GEM for Y. lipolytica (iMK735), Kavšček
et al. (2015) suggested a positive effect of oxygen limitation on lipid
production in the productive phase giving the hypothesis that re-
duced aeration rate, which is also favored in industry, might induce
lipid accumulation. Moreover, to eliminate citrate excretion, a re-
duced glycolytic flux was calculated while maintaining lipid synthesis
rate. Combination of these findings were used to design a fermen-
tation strategy which resulted in 80% increase in the lipid content of
biomass and more than fourfold yield improvement (Kavšček
et al., 2015). In a later model‐based approach, various gene knock-
outs and overexpression targets for improved TAG biosynthesis
were predicted by analyzing a comprehensive GEM reconstructed by
Wei et al. (2017) Although not experimentally verified, gene mod-
ification strategies mostly being involved in glycolytic and amino‐acid
metabolic pathways were predicted to yield over 55% increase on
TAG production. In a most recent model‐based study, a modified
version of iMK735 was implemented to analyze flux distributions of
Y. lipolytica in nitrogen‐limited conditions as well as identify meta-
bolic engineering strategies for improving lipid production. Since the
cellular objective of growing cells during nitrogen limitation is not
obvious, an environmental version of minimization of metabolic ad-
justment (eMOMA) was used instead of the conventional flux bal-
ance analysis (FBA) that requires an assumption of the cellular
objective, for example, maximized biomass production. This modeling
approach predicted multiple novel and nonintuitive targets for me-
tabolic engineering while experimental verification of one of the
knockout candidates involved in one‐carbon/methionine metabolism
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(annotated as methylenetetrahydrofolate dehydrogenase) showed
1.45‐fold increase in lipid accumulation (M. Kim et al., 2019).
As the current GEM‐based analyses rely on constraint‐based
analysis of the metabolic network stoichiometry, these models are
limited in providing insight into regulatory relationships, rate‐limiting
steps, or the effects of altering enzyme expression. Noteworthy is
that the current GEM‐based analyses did not include any regulatory
information. To address this limitation, kinetic models that quanti-
tatively describe the metabolic and regulatory processes through
kinetic formalisms (e.g., mass action, Michaelis–Menten; Foster
et al., 2021). Few examples of such models exist among non-
conventional yeast. In this regard, Robles‐Rodriguez et al. have built
and statistically validated three dynamic metabolic models of Y. li-
polytica to describe its lipid accumulation and citric acid production
while growing on glucose (Robles‐Rodriguez et al., 2017). Although,
no experimental validation has been sought, their results showed
acceptable fit of parameters so that they can potentially be im-
plemented to optimize lipid accumulation.
Despite the discussed progress, the power of genome‐scale
modeling is still limited for a biotechnologically favorable over-
production thus, the result of genetic interventions using this ap-
proach needs critical evaluation. In case of lipogenesis, this is also
since the lipid metabolism has proven to be quite complex in case of
Y. lipolytica and it indicates the need of incorporating more data into
genome‐scale models as discussed before. Moreover, multiple ap-
proaches can be used to overcome this issue amongst which bio-
process engineering (H. Liu et al., 2020), use of mixed substrates to
optimize metabolism (N. Liu et al., 2020), and cellular engineering
(Soong et al., 2019) can be named, discussion on which is out of the
scope of this review. However, implementing such approaches along
with existing metabolic engineering methods can potentially enhance
cell performance.
Generally, top‐down omics‐based approaches have not only
augmented the biological knowledge of lipid biosynthesis, but also in
some cases non‐experimentally verified suggestions for production
improvement have been concluded from these analyses. Of the
nonintuitive examples of these suggestions is the role of cell wall
biosynthesis genes in lipid production, shown by Pomraning et al.
(2015) where cell wall thickening was observed upon the exhaustion
of extracellular carbon source. Omics data such as fluxomics, in-
tracellular metabolomics, and proteomics can greatly help in under-
standing of the regulation of lipid metabolism, which in turn result in
targets for metabolic engineering of Y. lipolytica for the production of
lipids and fatty acid‐derived products. In all, more thorough combi-
nation of top‐down and bottom‐up approaches would therefore be
recommended.
4.2 | Specific oleochemicals
While classic and systems metabolic engineering efforts continue to
improve lipid production in Y. lipolytica by maximizing flux through
TAG biosynthesis, production of specific valuable oleochemicals are
being studied in this yeast mostly via synthetic pathway
construction.
Many commercially interesting oleochemicals, for example,
medium‐chain lipids, are less common in natural resources and
are therefore ideal candidates for systems and synthetic biology‐
based production due to their high value (Blazeck et al., 2014).
These oleochemicals can be used as nutraceuticals or pharma-
ceuticals, such as polyunsaturated fatty acids (PUFAs) or fatty
alcohols (Ledesma‐Amaro & Nicaud, 2016). Substantial progress
has been made towards heterologous production of such oleo-
chemicals in Y. lipolytica, but only recently have conclusions from
systems‐level analysis been implemented to improve the pro-
duction of nonnative oleochemicals. Most of these efforts are
through using the top‐down strategy. For instance, in a study by
Dahlin et al. (2019), a lipid degradation‐deficient strain of Y. li-
polytica was used as host organism to express copies of codon‐
optimized fatty acyl–CoA reductase from Marinobacter algicola.
The final fatty alcohol producer strain was evaluated by tran-
scriptomics, metabolomics, and fluxomics analysis. According to
the results, unlike S. cerevisiae, no elicited stress response was
detected in Y. lipolytica indicating the non‐toxicity of fatty alco-
hols in this strain. Moreover, potential limiting factors upstream
of acetyl–CoA, such as glucose uptake, glucose phosphorylation,
conversion to fructose‐6‐phosphate/fructose‐1,6‐bisphosphate
as well as pyruvate and citrate were indirectly predicted based
on metabolomic analysis (Dahlin et al., 2019). Transcriptomics of
another fatty alcohol producing Y. lipolytica aided to significantly
improve the production upon identifying the upregulation of
glycolysis genes in response to higher fatty alcohol production.
This result was leveraged to optimize the selection of suitable
promoters for fatty acyl‐CoA reductase expression,
to coordinate the fatty alcohol production with glycolysis
(Zhang et al., 2019).
To repurpose the lipophilic properties in Y. lipolytica for beta‐
carotene biosynthesis, Wang et al. designed a strategy of global
transcription machinery engineering (gTME) to explore the changes
of gene expression levels that benefits carotene production (M.
Wang, Li, et al., 2018). This strategy had been introduced for other
complex cellular genotypes in S. cerevisiae (El‐Rotail et al., 2017) and
Zymomonas mobilis (Tan et al., 2016). Accordingly, a library of ran-
domly mutated versions of the key transcription factor Yl‐Spt15
were expressed in a strain containing a heterologous beta‐carotene
biosynthetic pathway. Strains with mutated Yl‐Spt15 expression
displaying either enhanced or decreased production were analyzed
by transcriptomics, and the most dominant differentially expressed
genes were experimentally tested and those involved in RNA poly-
merase, fatty acid metabolism, and specially ketone body metabolism
were shown to be beneficial for beta‐Carotene production im-
provement. Although the reported beta‐carotene yields were far
lower compared to other published yields, their exploited gene tar-
gets and pathways can further guide the rational design of Y. lipo-
lytica for tuning lipophilic production in combination with improved
fermentation design.
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4.3 | Nonlipid products
Although a major focus in Y. lipolytica research is on lipogenesis,
this yeast is able to produce other native and nonnative in-
dustrially important chemicals such as organic acids (OAs) and
polyols. The most industrially important nonlipid chemicals are
OAs which are direct or indirect intermediates of the TCA cycle.
Due to its oleaginous phenotype, Y. lipolytica accommodates a
highly active TCA cycle. However, since biosynthesis of OAs is
highly linked to cellular energy metabolism, reaching efficient
production metrics will require more complex engineering ap-
proaches. This renders systems metabolic engineering profitable
tools to optimize OA production. Nonetheless, also for this group
of products has classical metabolic engineering through rational
genetic modifications and optimization of fermentation condition
shown to enhance the productivity (reviewed in Finogenova
et al., 2005). Meanwhile, efforts to elucidate the underlying
systems‐level production mechanisms are crucial to optimize cell
metabolism favorable for OA production. In terms of citric acid
(CA) production, Sabra et al. (2017) have focused on tran-
scriptome and fluxome data in a citrate producing strain of Y.
lipolytica. While controlling the oxygen supply on mixed sub-
strates proved instrumental to improve the citrate production
titer more than three fold, multiomics data analysis have pro-
vided pentose phosphate pathway and glyoxylate cycle genes as
targets for metabolic engineering of CA (Sabra et al., 2017). In
another study, after reporting Y. lipolytica as the best CA pro-
ducer among more than 40 yeast strains, Kamzolova et al. (2017),
studied the underlying overproduction mechanism using growth
limitation assessment and enzyme activity measurements which
helped in fermentation design for enhanced production (85 g/L).
A more recent screening also showed that the production of CA
strongly strain dependent, therefore, screening for over-
producers and studying the underlying molecular mechanisms is
of great importance (Carsanba et al., 2019). Noteworthy is that
due to the relations between lipid and CA metabolism, knowl-
edge of the regulation surrounding lipid accumulation as well as
nitrogen limitation can have considerable relevance for CA pro-
duction studies.
The production of succinic acid (SA) in Y. lipolytica has also
undergone metabolic engineering efforts (Abdel‐Mawgoud
et al., 2018). Unlike SA‐producing bacteria, which are among
the most successful producers to date, Y. lipolytica can tolerate
low pH and thrives under acidic conditions. This simplifies
downstream processes as the bacterial fermentation broth is
rather kept near‐neutral pH and requires an additional acid-
ification step for SA purification which causes byproduct for-
mation (Ahn et al., 2016). Although high titers have been
achieved (160 g/L) in an engineered strain lacking active succi-
nate dehydrogenase (SDH) to prevent oxidation of succinic acid
to fumaric acid, low yield and productivity hinders the im-
plementation of Y. lipolytica for industrial production. SDH defi-
cient mutants of Y. lipolytica are growth defective in cultures
using glucose source (Yuzbashev et al., 2010). To circumvent this
problem Yuzbashev et al. have isolated an improved SA producer
from combined induced mutagenesis and metabolic evolution,
which could more efficiently utilize glucose (Yuzbashev
et al., 2016). 13C flux analysis on SDH deficient mutants was
performed to investigate the contribution of various metabolic
pathways in SA formation (Yuzbashev et al., 2016), however, to
fully reveal the molecular mechanism by which adaptive evolu-
tionary approaches have resulted in a beneficial phenotype
would require genome sequence analysis of the evolved and
unevolved strains. A further problem hindering improvement of
SA production is the accumulation of the by‐product acetate (Cui
et al., 2017). By metabolic pathway analysis, Cui et al. have re-
ported CoA‐transferase activity in mitochondria as the major
source of acetic acid. Deletion of the responsible gene, as well as
further overexpression of the key enzymes of the oxidative TCA
resulted in an improved SA titer and no acetic acid accumulation
in defined media (Cui et al., 2017). There have been successful
systems metabolic engineering approaches for SA production in
other microorganisms, such as GEM‐based SA production im-
provement on S. cerevisiae (Agren et al., 2013) as well as other
omics‐based studies (Otero et al., 2013). Similar approaches
could be applied to Y. lipolytica to yield industrially feasible SA
production levels in this yeast.
α‐ketoglutarate (α‐KG) is another OA for which Y. lipolytica
seems a promising production host. The main strategy being used
to improve its production is still based on fermentation design as
well as a few genetic engineering in the direct biosynthetic en-
zymes (H. Guo et al., 2016). Therefore, while systems‐level in-
sight is still desired to investigate key metabolic processes
influenced and regulated by the known factors that positively
affect α‐KG production, there are a few studies based on omics
data. In a study to improve α‐KG production, Guo et al., have
assessed the roles of specific transporters (H. Guo et al., 2015).
To this end, they have identified six endogenous putative trans-
porter genes using a comparative genomics approach and by
expressing them in an α‐KG‐producing wild‐type strain, the
production of this OA has improved while reduced pyruvic acid (a
byproduct) concentration was observed. Their study showed
whole genome analysis for transporters can be helpful in im-
proving the accumulation of specific organic acids. Another
comparative genomics method with the aim of investigating the
regulatory mechanisms controlling α‐KG production, showed the
positive role of genes associated with the regulation of mi-
tochondrial biogenesis and energy metabolism in α‐KG produc-
tion, whereas they have concluded genes related to
transformation between keto acids and amino acids as reducers
of the accumulation of α‐KG (Zeng et al., 2016). As another
strategy to accumulate α‐KG, is to take advantage of its thiamine‐
auxotrophic trait. Y. lipolytica is unable to biosynthesize thiamine
which is the co‐factor for α‐ketoglutarate dehydrogenase which
converts α‐KG to succinyl‐CoA. Therefore, a culture medium
lacking this vitamin will likely favor the accumulation of α‐KG
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when carbon source is in excess. However, enhanced accumula-
tion of α‐KG by disruption of genes directly affecting TCA cycle
will undoubtedly cause cellular growth and survival defects cir-
cumventing which urges deeper molecular knowledge. In this
regard, similar omics data‐based findings of the study by Walker
et al. on the effects of thiamine deficiency on cellular metabolism
of thiamine auxotroph Y. lipolytica which was discussed in lipid
production improvement strategies, can be helpful (Walker
et al., 2020).
Beyond native OAs, Y. lipolytica has been used to produce the
nonnative itaconic acid (IA). IA is naturally produced by several As-
pergillus species and is a replacement for petroleum derived products
(Robert & Friebel, 2016). Due to shortcomings with the native pro-
ducer in terms of poor growth and shear stress sensitivity, its pro-
duction is studied in alternative hosts such as Y. lipolytica. IA is
synthesized by cis‐aconitic acid decarboxylase (CAD) (Kanamasa
et al., 2008) and IA production in Y. lipolytica has been established by
heterologous expression of CAD (Blazeck et al., 2015) resulting in IA
yields of 0.06 g/(g glucose) at natural low pH. Although these studies
can serve as a promising stepping‐stone toward enhancing IA pro-
duction in Y. lipolytica, to establish this yeast as an industrially
competitive IA producer, further efforts are required to improve
production metrics. Even while bottom‐up systems‐level approaches
have been used for IA production in other microorganisms (Harder
et al., 2016), there is still no report on systems metabolic engineering
in Y. lipolytica.
Besides OAs, Y. lipolytica is a promising producer of sugar poly-
ols, and there is a currently strong interest in bio‐based production
of such value‐added functional sugars for use in food and pharma-
ceuticals industry as sweetener (e.g. mannitol and erythritol). Recent
progress in the use of Y. lipolytica to synthesize these functional
sugars, especially the genetic engineering approaches, are compre-
hensively reviewed elsewhere (Bilal et al., 2020). The importance of
systems‐level studies in this field has been demonstrated in a study
by Yang et al. where erythritol production could be enhanced in an
osmophilic strain of Y. lipolytica by cultivation in an osmotic pressure
control fed‐batch strategy (L. B. Yang et al., 2014). Proteomics of
erythritol production from glycerol in response to osmotic pressure
revealed that highly ranked differentially‐expressed proteins such as
enzymes related to osmotic stress response, the aldo‐keto re-
ductases and catalase T had drastically increased expression levels
under hyperosmotic pressure (L. B. Yang et al., 2015). This in-
formation could be leveraged on for future reverse engineering of Y.
lipolytica strains for polyols biosynthesis.
Production of many pharmaceuticals and nutraceuticals em-
ploying Y. lipolytica as a host has been studied mostly using classic
metabolic engineering (Zhang et al., 2020). Oleanolic acid is penta-
cyclic triterpenoid with antioxidation activity and its heterologous
production have been studied in Y. lipolytica. Based on intracellular
metabolome data, a direct precursor of the triterpenoid was found to
be accumulating. Guided by the analysis of differential transcrip-
tional levels of genes, it transpired that enhancement of electron
transfer by fusion expression of P450 enzyme and the last step of
the biosynthetic pathway could be used to improve substrate con-
version efficiency by 28% (Li et al., 2020).
5 | CONCLUSIONS AND PERSPECTIVES
For decades, Y. lipolytica has been known as a promising biotechno-
logical chassis not only for its high oleaginous flux, but also for the
production of a variety of native and nonnative chemicals. However,
despite advances in genome editing tools which have facilitated
classical metabolic engineering of Y. lipolytica, production metrics for
most products still needs improvement. Questions remain on how to
overcome limitations in growth characteristics, substrate degrada-
tion and product formation. In this regard, systems biology allows a
more in‐depth understanding of the intricate regulation and meta-
bolism which can further help in identifying nonintuitive strain de-
sign targets with the aim of pushing yields to the theoretical limits.
This can in turn expand the industrial potential of this yeast. Al-
though several Y. lipolytica strain engineering studies have begun to
involve omics and model‐based approaches, there is significant po-
tential in further use of effective systems‐level approaches. More-
over, systems‐level approaches have been used for studying lipid‐
derived products with some promising results, while non‐lipid pro-
ducts have benefited very little. Furthermore, both bottom‐up and
top‐down approaches are used, although not to the same extend in
all the products of Y. lipolytica. A number of specific next steps can be
identified to push this field further.
5.1 | Combination of top‐down and bottom‐up
approaches
As classical metabolic engineering results typically show, the over-
expression of a gene target and in vivo production improvement are
rarely linearly correlated, which is believed to be caused by various
layers of cellular control. To this end, a combination of both the top‐
down and bottom‐up approaches seems promising to elucidate the
effect of genetic interventions. As GEMs allow for incorporating
gene, transcript, protein and reaction relationships, they are capable
to be efficiently used as scaffolds for omics data integration to refine
their reconstruction as well as defining accurate constrains on flux
predictions. This will consequently result in not only improved pre-
dictions of cellular phenotype or product formations but also will
help gaining insight into regulation of metabolism in response to
environmental or genetic perturbations. In this regard, advance-
ments in metabolomics data generation and analysis in yeasts
(Sailwal et al., 2020) could be employed for Y. lipolytica research and
assist in learning about its pathway to further aid in metabolic en-
gineering. Accordingly, while inferring exchange fluxes from extra-
cellular measurements can be used for more accurate FBA
simulations, direct integration of intracellular metabolite con-
centrations withing the FBA framework is challenging due to the
quasi‐steady state assumption in GEMs (Pandey et al., 2019).
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However, these data can still be used to improve the GEM by finding
reactions directionality as well as finding missing functions. Ad-
ditionally, analysis of metabolomics data alone or in combination
with proteomics data, can promise accurate assessment of pathway
flux, cofactor imbalance as well as carbon balance diversion which
will further aid in finding pathway bottlenecks in strain design
(Amer & Baidoo, 2021).
Integration of transcriptomics data gives insight on whether flux
distributions are transcriptionally regulated which in turn represent
suitable targets for metabolic engineering to rationally altering
fluxes. Although being a more frequently used strategy in omics data
integration studies, availability of transcriptomics from different
culture conditions and mutant strains will improve the strain design
for Y. lipolytica. At the same time, since the regulation of a biological
function may occur across the different levels, combination of ad-
ditional levels of information such as proteomics, metabolomics and
fluxomics can be used for better identification of active regulatory
paths. Although yet challenging, using GEMs as a scaffold for in-
tegration of multiple levels is a foreseeable strategy to be im-
plemented particularly due to advancements of computational
algorithms being developed for data integration. However, this will
require careful experimental considerations in terms of generating
data sets which must be all from the same media, culture condition
and strain.
5.2 | Complete the genome annotation
A notable obstacle limiting the impact of systems‐level metabolic
engineering is that many Y. lipolytica gene products (ca. 40% in case
of strain W29) are annotated as hypothetical proteins, which can
hinder the interpretation of data‐driven information as well as pre-
dictive efficacy of genome‐based models. This need for a more
complete annotation of the Y. lipolytica genome can at least partially
be addressed using available computational approaches, where for
example, recent advances in machine learning can accurately predict
both translation start sites and functional annotations (G. B. Kim
et al., 2020). Artificial neural networks, clustering and other machine‐
learning algorithms have shown promising results in biosynthetic
pathway prediction for a target chemical (Segler et al., 2018) (useful
in nonnative chemical productions), prediction of a probability that
an enzyme catalyzes a reaction (Mellor et al., 2016) (useful in GEM
reconstruction), and different gene expression control parameter
prediction such as promoter strength (Jervis et al., 2019) (useful in
metabolic engineering). While computational functional genomics
inevitably yields a certain proportion of incorrect predictions, in
contrast to detailed experimental validation of gene function through
molecular biology studies, having a hypothetical functional annota-
tion is arguable more informative than having no annotation for ca.
40% of the genome. Besides, this highlights the continuing value of
low‐throughput detailed characterization of gene functions, which
should not be all superseded by high‐throughput multi‐omics
approaches.
5.3 | Advances in computational approaches
Regardless of the incomplete genome annotation, the current
knowledge can be used to improve the existing computational
models. A robust and accurate metabolic model facilitates successful
application but relies on the availability of sufficient experimental
data. While the Y. lipolytica GEM has been improved (Xu et al., 2020),
this should continue akin to the continuous curation and in-
corporation of new experimental data in the S. cerevisiae GEM.
Specifically, the S. cerevisiae GEM has been advanced by integrating
enzymatic constraints as well as protein 3D structures, now ren-
dering this model capable of accurately predicting how single nu-
cleotide variations translate to phenotypic traits (Lu et al., 2019).
Such strategies are expected to also be of value for nonconventional
yeasts such as Y. lipolytica.
The lack of kinetic parameters has precluded wider use of kinetic
models of Y. lipolytica, but this impediment could be countered
through ensemble modeling (EM). Instead of settling on specific
parameter values, in EM samples of kinetic parameters are re-
peatedly drawn from an allowable distribution to generate an en-
semble of kinetic models that best describe the system under study
(Tran et al., 2008). EM has been used in systems metabolic en-
gineering to among others identify targets for improved ethanol
overproduction in Synechocystis sp. PCC 6803 (Nishiguchi
et al., 2019; Nishiguchi et al., 2020); overproduction of L‐lysine in
Escherichia coli (Contador et al., 2009); as well as improved ethanol
production in Clostridium autoethanogenum (Greene et al., 2019).
Applying this approach in Y. lipolytica might be a valuable strategy to
further the understanding of its metabolic dynamics and identify
novel strategies for improved production, although it should be no-
ted that selection of ensemble models depends on the availability of
(dynamic) experimental data from diverse conditions, which is cur-
rently relatively limited for Y. lipolytica. In particular dynamic meta-
bolomics measurements would contribute valuable criteria to narrow
down the solution space described by ensemble models.
Alternatively, existing GEMs could be expanded to allow for
integration of further omics data, thereby yielding more accurate
predictions of gene modification targets. A classical GEM can, for
example, be expanded by introducing enzymatic constraints, where
the usage and efficiency of enzymes is explicitly considered (Sánchez
et al., 2017). Such enzyme constrained models (ec‐models) do not
only yield flux distributions that physiologically more relevant, but
they also enable the integration of proteomics data to result in
condition‐specific models. However, ec‐models require enzyme effi-
ciencies as kcat values that are sparsely available for Y. lipolytica.
While kcat values could be estimated from related organisms, it is
anticipated that machine‐learning will be able to give more accurate
predictions (Heckmann et al., 2018). GEMs could also be further
expanded towards genome‐scale models of metabolism and expres-
sion (ME‐models), enabling the integration of gene expression and
protein synthesis data in GEMs. This approach has been used in, for
example, E. coli (O′brien et al., 2013) and S. cerevisiae (Oftadeh
et al., 2021), but has not been widely applied to non‐model
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microorganisms primarily due to the lack of species‐specific detailed
knowledge of, for example, protein synthesis.
In sum, the increasing availability of systems‐level tools and
techniques such as genome modification tools, metabolic models
and state‐of‐the‐art “omics” studies, are able to enhance our
understanding of unique Y. lipolytica features and provide gui-
dance for its improvement. However, it remains imperative that a
deeper knowledge of regulation and metabolism in Y. lipolytica
will help to advance it towards a versatile industrial cell‐factory.
Largely, this can be accomplished by orthogonal application of
systems‐level and synthetic biology tools that have been very
successful to advance model organisms such as S. cerevisiae into
promising cell factories, while its unique characteristics can give
Y. lipolytica an advantage. Moreover, as Y. lipolytica can be re-
garded as a promising host for the biosynthesis of various pro-
ducts, it is expected that elucidation of systems‐level behaviors
for one product will also positively impact on this yeast as a
future host for other products.
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